| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 12 Nov 2025 | 6 Nov 2025 |
| Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 inter alia to consider and approve the unaudited financial results of the Company for quarter and half year ended on September 30 2025. Outcome of the Board Meeting held on Wednesday, November 12, 2025 pursuant to Regulations 30, 33 and other applicable Regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement Dated on 12.11.2025) | ||
| Board Meeting | 13 Aug 2025 | 7 Aug 2025 |
| Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) of the Company for quarter ended June 30 2025 and to recommend final dividend. To Considered and approved the unaudited financial results of the Company for quarter ended June 30, 2025 and recommendation of payment of final dividend. (As per BSE Announcement Dated on 13/08/2025) | ||
| Board Meeting | 27 May 2025 | 2 May 2025 |
| Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2025 inter alia to consider and approve the audited Financial Results of the Company for the Quarter and year ended on March 31 2025 Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 ,inter alia, to consider and approve Consideration And Approval Of The Audited Financial Results Of The Company For The Quarter And Year Ended On March 31, 2025 (As per BSE Announcement Dated on 09/05/2025) Outcome of Board meeting (As Per BSE Announcement dated on 27.05.2025) | ||
| Board Meeting | 1 Feb 2025 | 27 Jan 2025 |
| Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2025 inter alia to consider and approve the un-audited Financial Results of the Company for the quarter ended on December 31 2024. Considered and approved the unaudited financial results (standalone and consolidated) of the Company for the quarter ended on December 31, 2024. Intimation of Investment in Axiodent Inc. (As Per BSE Announcement Dated on: 01/02/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.